INFLUXInflux Healthtech Ltd.

₹169+0.00%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

No Shareholding Data

Shareholding information is not available for this stock.

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Influx Healthtech Ltd. stands out in the Pharmaceuticals & Drugs sector, with solid profitability metrics and a favorable valuation profile compared to its peers. Notably, it exhibits strong growth, particularly in revenue and EPS, while maintaining a low debt level, making it a compelling option for investors seeking both growth and stability.

Key Points

• Influx Healthtech Ltd. shows strong revenue and EPS growth.
• The target company has a favorable debt-to-equity ratio compared to most peers.
• Several companies in the sector are overvalued relative to their growth and profitability metrics.

Top Performers

Cipla Ltd.

Strong profitability with low PE and high ROE, indicating efficiency and value.

Dr. Reddy's Laboratories Ltd.

Excellent growth trajectory with strong profitability metrics and low valuation ratios.

Mankind Pharma Ltd.

Robust growth with high ROE and low debt levels, showcasing financial health.